Edwards Lifesciences Corporation P/E Ratio 2008–2025
Edwards Lifesciences Corporation reported 46.58 of price-to-earnings ratio for fiscal 2025. That was 338.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -33.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 46.58 | +338.6% |
| FY 2024 | 10.62 | -68.0% |
| FY 2023 | 33.15 | +8.4% |
| FY 2022 | 30.58 | -43.8% |
| FY 2021 | 54.43 | -22.4% |
| FY 2020 | 70.18 | +48.0% |
| FY 2019 | 47.42 | +4.9% |
| FY 2018 | 45.18 | +8.2% |
| FY 2017 | 41.74 | +16.3% |
| FY 2016 | 35.90 | +2.3% |
| FY 2015 | 35.10 | +3.1% |
| FY 2014 | 34.06 | +77.1% |
| FY 2013 | 19.23 | -47.5% |
| FY 2012 | 36.65 | +2.7% |
| FY 2011 | 35.71 | -19.2% |
| FY 2010 | 44.17 | +98.4% |
| FY 2009 | 22.27 | +78.3% |
| FY 2008 | 12.49 | — |
Source: Edwards Lifesciences Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open EW 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Edwards Lifesciences Corporation reported 46.58 of price-to-earnings ratio for fiscal 2025. That was 338.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -33.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Edwards Lifesciences Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEdwards Lifesciences Corporation — frequently asked questions
What is Edwards Lifesciences Corporation's price-to-earnings ratio?
Edwards Lifesciences Corporation (EW) reported price-to-earnings ratio of 46.58 for fiscal year 2025, per its SEC filings.
How has Edwards Lifesciences Corporation's price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, EW's price-to-earnings ratio grew at roughly 8.1% per year (compound annual rate), from 12.49 to 46.58.
Where does this data come from?
Figures are computed from Edwards Lifesciences Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More EW financial history
Full EW fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →